5 mcg/actuation) inhaled PO qDay
5 mcg, and SPIRIVA HANDIHALER are indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and for reducing COPD exacerbations
Redovna upotreba leka Spiriva Respimat može da Vam pomogne kada zbog bolesti kratko i plitko dišete, može Vam pomoći da na najmanju meru svedete uticaj bolesti na Vaš svakodnevni život
Asthma patients must be advised to continue taking anti-inflammatory therapy, i
Spiriva® Respimat®, inhalationsvæske, opløsning
Click to view Spiriva Respimat detailed prescribing information
Infants & childn
5 mcg, and SPIRIVA HANDIHALER are long-term, once-daily, prescription maintenance medicines used to control symptoms of chronic obstructive pulmonary disease (COPD) by relaxing your airways and keeping them open
5 mcg
This treatment can also reduce the likelihood of COPD flare-ups or exacerbations
Difficulty in sleeping (insomnia) Rare Uncommon Irregular heart beat (atrial fibrillation, supraventricular tachycardia) Rare Not known The use of Spiriva Respimat resulted in a reduction of rescue bronchodilator use compared to placebo (mean reduction in rescue use 0
The bronchodilator effects of Spiriva Respimat were maintained throughout the 1-year period of administration with no evidence of tolerance